Establishment of canine RNA polymerase I-driven reverse genetics for influenza A virus: Its application for H5N1 vaccine production

Journal of Virology

Volumn 82, Issue 3, 2008, Pages 1605-1609

  Murakami, Shin ^a   Horimoto, Taisuke ^a,b   Yamada, Shinya ^a,b   Kakugawa, Satoshi ^a,b   Goto, Hideo ^a,b   Kawaoka, Yoshihiro ^a,b,c  

^a UNIVERSITY OF TOKYO   (Japan)

^b JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

^c UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA DIRECTED RNA POLYMERASE; INFLUENZA VACCINE;

ANIMAL CELL; ANTIGENICITY; ARTICLE; CELL LINE; CONTROLLED STUDY; DOG; GENE SEQUENCE; INFLUENZA VIRUS A; INFLUENZA VIRUS A H5N1; KIDNEY CELL; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; VIRAL GENETICS; VIRUS STRAIN;

ANIMALS; CELL LINE; DOGS; INFLUENZA A VIRUS; INFLUENZA A VIRUS, H5N1 SUBTYPE; INFLUENZA VACCINES; PROMOTER REGIONS (GENETICS); RNA POLYMERASE I; RNA, VIRAL; VIRAL PROTEINS;

CERCOPITHECUS AETHIOPS; INFLUENZA A VIRUS; ORTHOMYXOVIRIDAE;

EID: 38349122200     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.01876-07     Document Type: Article

References (22)

1. Brands, R., J. Visser, J. Medema, A. M. Palache, and G. J. van Scharrenburg. 1999. Influvac: a safe Madin Darby canine kidney (MDCK) cell culture-based influenza vaccine. Dev. Biol. Stand. 98:93-100, 111.
2. de Wit, E., M. I. Spronken, G. Vervaet, G. F. Rimmelzwaan, A. D. Osterhaus, and R. A. Fouchier. 2007. A reverse-genetics system for influenza A virus using T7 RNA polymerase. J. Gen. Virol. 88:1281-1287.
3. Fodor, E., L. Devenish, O. G. Engelhardt, P. Palese, G. G. Brownlee, and A. García-Sastre. 1999. Rescue of influenza A virus from recombinant DNA. J. Virol. 73:9679-9682.
4. Govorkova, E. A., S. Kodihalli, I. V. Alymova, B. Fanget, and R. G. Webster. 1999. Growth and immunogenicity of influenza viruses cultivated in Vero or MDCK cells and in embryonated chicken eggs. Dev. Biol. Stand. 98:39-51, 73-74.
5. Halperin, S. A., B. Smith, T. Mabrouk, M. Germain, P. Trepanier, T. Hassell, J. Treanor, R. Gauthier, and E. L. Mills. 2002. Safety and immunogenicity of a trivalent, inactivated, mammalian cell culture-derived influenza vaccine in healthy adults, seniors, and children. Vaccine 20:1240-1247.
6. Hoffmann, E., G. Neumann, Y. Kawaoka, G. Hobom, and R. Webster. 2000. A DNA transfection system for generation of influenza A virus from eight Plasmids. Proc. Natl. Acad. Sci. USA 97:6108-6113.
7. Horimoto, T., and Y. Kawaoka. 2005. Influenza: lessons from past pandemics, warnings from current incidents. Nat. Rev. Microbiol. 3:591-600.
8. Horimoto, T., S. Murakami, Y. Muramoto, S. Yamada, K. Fujii, M. Kiso, K. Iwatsuki-Horimoto, Y. Kino, and Y. Kawaoka. 2007. Enhanced growth of seed viruses for H5N1 influenza vaccines. Virology 366:23-27.
9. Horimoto, T., A. Takada, K. Fujii, H. Goto, M. Hatta, S. Watanabe, K. Iwatsuki-Horimoto, M. Ito, Y. Tagawa-Sakai, S. Yamada, H. Ito, T. Ito, M. Imai, S. Itamura, T. Odagiri, M. Tashiro, W. Lim, Y. Guan, M. Peiris, and Y. Kawaoka. 2006. The development and characterization of H5 influenza virus vaccines derived from a 2003 human isolate. Vaccine 24:3669-3676.
10. Lindblad-Toh, K., C. M. Wade, T. S. Mikkelsen, E. K. Karlsson, D. B. Jaffe, M. Kamal, M. Clamp, J. L. Chang, E. J. Kulbokas III, M. C. Zody, E. Mauceli, X. Xie, M. Breen, R. K. Wayne, E. A. Ostrander, C. P. Ponting, F. Galibert, D. R. Smith, P. J. DeJong, E. Kirkness, P. Alvarez, T. Biagi, W. Brockman, J. Butler, C. W. Chin, A. Cook, J. Cuff, M. J. Daly, D. DeCaprio, S. Gnerre, M. Grabherr, M. Kellis, M. Kleber, C. Bardeleben, L. Goodstadt, A. Heger, C. Hitte, L. Kim, K. P. Koepfli, H. G. Parker, J. P. Pollinger, S. M. Searle, N. B. Sutter, R. Thomas, C. Webber, J. Baldwin, A. Abebe, A. Abouelleil, L. Aftuck, M. Ait-Zahra, T. Aldredge, N. Allen, P. An, S. Anderson, C. Antoine, H. Arachchi, A. Aslam, L. Ayotte, P. Bachantsang, A. Barry, T. Bayul, M. Benamara, A. Berlin, D. Bessette, B. Blitshteyn, T. Bloom, J. Blye, L. Boguslavskiy, C. Bonnet, B. Boukhgalter, A. Brown, P. Cahill, N. Calixte, J. Camarata, Y. Cheshatsang, J. Chu, M. Citroen, A. Collymore, P. Cooke, T. Dawoe, R. Daza, K. Decktor, S. DeGray, N. Dhargay, K. Dooley, P. Dorje, K. Dorjee, L. Dorris, N. Duffey, A. Dupes, O. Egbiremolen, R. Elong, J. Falk, A. Farina, S. Faro, D. Ferguson, P. Ferreira, S. Fisher, M. FitzGerald, K. Foley, et al. 2005. Genome sequence, comparative analysis and haplotype structure of the domestic dog. Nature 438:803-819.
11. Massin, P., P. Rodrigues, M. Marasescu, S. van der Werf, and N. Naffakh. 2005. Cloning of the chicken RNA polymerase I promoter and use for reverse genetics of influenza A viruses in avian cells. J. Virol. 79:13811-13816.
12. Montagnon, B. J., J. C. Vincent-Falquet, and J. F. Saluzzo. 1999. Experience with Vero cells at Pasteur Merieux Connaught. Dev. Biol. Stand. 98:137-140, 167.
13. Neumann, G., K. Fujii, Y. Kino, and Y. Kawaoka. 2005. An improved reverse genetics system for influenza A virus generation and its implications for vaccine production. Proc. Natl. Acad. Sci. USA 102:16825-16829.
14. Neumann, G., T. Watanabe, H. Ito, S. Watanabe, H. Goto, P. Gao, M. Hughes, D. R. Perez, R. Donis, E. Hoffmann, G. Hobom, and Y. Kawaoka. 1999. Generation of influenza A viruses entirely from cloned cDNAs. Proc. Natl. Acad. Sci. USA 96:9345-9350.
15. Nicolson, C., D. Major, J. M. Wood, and J. S. Robertson. 2005. Generation of influenza vaccine viruses on Vero cells by reverse genetics: an H5N1 candidate vaccine strain produced under a quality system. Vaccine 23:2943-2952.
16. Ozawa, M., K. Fujii, Y. Muramoto, S. Yamada, S. Yamayoshi, A. Takada, H. Goto, T. Horimoto, and Y. Kawaoka. 2007. Contributions of two nuclear localization signals of influenza A virus nucleoprotein to viral replication. J. Virol. 81:30-41.
17. Ozawa, M., H. Goto, T. Horimoto, and Y. Kawaoka. 2007. An adenovirus vector-mediated reverse genetics system for influenza A virus generation. J. Virol. 81:9556-9559.
18. Paule, M. R., and R. J. White. 2000. Survey and summary: transcription by RNA polymerases I and III. Nucleic Acids Res. 28:1283-1298.
19. Schultz, M. C., S. Y. Choė, and R. H. Reeder. 1993. In vitro definition of the yeast RNA polymerase I enhancer. Mol. Cell. Biol. 13:2644-2654.
20. Subbarao, K., H. Chen, D. Swayne, L. Mingay, E. Fodor, G. Brownlee, X. Xu, X. Lu, J. Katz, N. Cox, and Y. Matsuoka. 2003. Evaluation of a genetically modified reassortant H5N1 influenza A virus vaccine candidate generated by plasmid-based reverse genetics. Virology 305:192-200.
21. Webby, R. J., D. R. Perez, J. S. Coleman, Y. Guan, J. H. Knight, E. A. Govorkova, L. R. McClain-Moss, J. S. Peiris, J. E. Rehg, E. I. Tuomanen, and R. G. Webster. 2004. Responsiveness to a pandemic alert: use of reverse genetics for rapid development of influenza vaccines. Lancet 363:1099-1103.
22. Wood, J. M., and J. S. Robertson. 2004. From lethal virus to life-saving vaccine: developing inactivated vaccines for pandemic influenza. Nat. Rev. Microbiol. 2:842-847.